Harness IP
  • People
  • Global IP Services
    • Practice Areas
    • Industries
    • Case Studies
  • Blog
  • News & Awards
  • About Us
  • Careers
  • Contact Us
    • 한국어
    • 日本語
    • 中國語
  • Client Login
  • 한국어
  • 日本語
  • 中國語

Blog

Stay Current on all things IP by subscribing to our blog

Join

Harness IP takes pride in our collective knowledge of intellectual property law and how it affects businesses and organizations across a range of industries. We also enjoy keeping up with the latest decisions from the prominent venues that affect IP law, including the Federal Circuit, the U.S. Supreme Court, and the PTAB. Our goal is to distill this knowledge into practical guidance that in-house counsel and others can use. We invite you to join our audience and enrich the discussion whenever possible. 

  • Biologics & Biosimilars

      ALL CATEGORIES

      • Biologics & Biosimilars
        • FDA Guidance & Updates
      • BioPharma
      • Blockchain, Crypto, & Web 3.0
      • Chemistry & Nanotechnology
      • EDMO Patent Updates
      • Fitness IP
      • IP Management
      • IPR-PGR
      • Litigation
      • Patent Prosecution
      • quIPs
      • Trademarks
      • Uncategorized
  • Authors
    • Caley BennettCaley Bennett 3
    • Jewell N. BriggsJewell N. Briggs 8
    • John A. Castellano, IIIJohn A. Castellano, III 1
    • Christopher M. CaubleChristopher M. Cauble 5
    • Christopher R. ClaytonChristopher R. Clayton 1
    • Matthew L. CutlerMatthew L. Cutler 202
    • Keith P. DriscollKeith P. Driscoll 1
    • Nicholas S. DrysdaleNicholas S. Drysdale 7
    • Monte L. FalcoffMonte L. Falcoff 3
    • Jeremiah J. FoleyJeremiah J. Foley 1
    • Glenn E. ForbisGlenn E. Forbis 12
    • Charlie Franklin, Ph.D.Charlie Franklin, Ph.D. 1
    • Alexandra M. FuchsAlexandra M. Fuchs 3
    • Michael GambleMichael Gamble 1
    • Jordyn GraweJordyn Grawe 11
    • Jason A. HeistJason A. Heist 1
    • Paul R. HofferPaul R. Hoffer 3
    • Michael P. KellaMichael P. Kella 4
    • Hemant M. KeskarHemant M. Keskar 4
    • Sung Pil KimSung Pil Kim 1
    • Elisabeth A. KoralElisabeth A. Koral 12
    • Kisuk LeeKisuk Lee 4
    • Jeffrey LinJeffrey Lin 2
    • J. Bradley (Brad) LuchsingerJ. Bradley (Brad) Luchsinger 1
    • Chris K. MillerChris K. Miller 1
    • Leanne M. RakersLeanne M. Rakers 37
    • Douglas A. RobinsonDouglas A. Robinson 20
    • Joel R. SamuelsJoel R. Samuels 16
    • Mark A. SpinelliMark A. Spinelli 1
    • David L. SuterDavid L. Suter 2
    • Michael L. TaylorMichael L. Taylor 1
    • Jennifer R. TurchynJennifer R. Turchyn 4
    • David P. UtykanskiDavid P. Utykanski 2
    • Michael VarcoMichael Varco 5
    • Colette E. VerchColette E. Verch 1
    • Joseph E. Walsh, Jr.Joseph E. Walsh, Jr. 4
    • Andrew M. WaxmanAndrew M. Waxman 2
    • Bryan K. WheelockBryan K. Wheelock 720
    • Kaylynn WilliamsonKaylynn Williamson 1
    • Jennifer M. Woodside WojtalaJennifer M. Woodside Wojtala 12
    • Scott E. YackeyScott E. Yackey 1
  • CHEMICAL & LIFE SCIENCE PATENTS_Q2 CLS Newsletter

    July 7, 2025

    U.S. Chemical & Life Science Patents Q2 Newsletter

    More

  • 5 Federal Circuit Patent Cases You Need To Know

    June 30, 2025

    5 Federal Circuit Patent Cases You Need To Know

    More

  • Enablement, Anticipation, and Claim Strategy

    June 26, 2025

    Enablement, Anticipation, and Claim Strategy: Rethinking Biotech Patent Drafting Post-Agilent

    More

  • Six Actions to Take to Ensure Your Trade Secret Stays Secret

    June 23, 2025

    Six Actions to Take to Ensure Your Trade Secret Stays Secret

    More

  • GettyImages 2207660420 | Intellectual Property Law Firm | Harness IP

    June 23, 2025

    Cannabis And Trademarks: Protecting Against Infringement

    More

  • The Hypocrisy of ‘Delete IP’

    May 13, 2025

    The Hypocrisy of ‘Delete IP’: Billionaire Frustrations Masquerading as Policy

    More

CHEMICAL & LIFE SCIENCE PATENTS_Q2 CLS Newsletter

July 7, 2025

U.S. Chemical & Life Science Patents Q2 Newsletter

By: Caley Bennett, Associate; Christopher R. Clayton, Associate; Jordyn Grawe, Patent Agent; Elisabeth A. Koral, Principal; Kisuk Lee, Principal; Jeffrey Lin, Associate; Leanne M. Rakers, Principal; Douglas A. Robinson, Principal; Michael Varco, Principal

Xencor Jepson claim

May 12, 2025

A Path to Antibody Protection

By: Caley Bennett, Associate

CLS Newsletter

April 4, 2025

U.S. Chemical & Life Science Patents Quarterly Newsletter

By: Caley Bennett, Associate; Jordyn Grawe, Patent Agent; Michael Varco, Principal; Leanne M. Rakers, Principal

FDA NIH | Intellectual Property Law Firm | Harness IP

December 16, 2024

20 March 2024 USPTO Alert: USPTO ensures robust and reliable patents through examiner training on searching for prior art in FDA and NIH databases

By: Leanne M. Rakers, Principal; Jordyn Grawe, Patent Agent

Extrinsic-Evidence_Harness-IP_Intellectual-Property-Law-Firm

November 6, 2023

Extrinsic Evidence Needed to Construe Numerical Limitation in the Claims

By: Bryan K. Wheelock, Principal

WIPO Standard ST.26 Tips_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP

October 5, 2022

WIPO Standard ST.26 Tips as of 16 August 2022

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

WIPO resources_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP

September 28, 2022

WIPO ST.26 Resources

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

WIPO sequence features_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_

September 21, 2022

Features of WIPO Sequence

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

WIPO ST.25 vs ST.26_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_

September 13, 2022

ST.25 vs. ST.26 Sequence Listings

By: Leanne M. Rakers, Principal; Jordyn Grawe, Patent Agent

WIPO ST.26_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_

September 7, 2022

WIPO ST.26 Overview

By: Jordyn Grawe, Patent Agent; Leanne M. Rakers, Principal

Harness IP_Intellectual Property_The Big Bang Blog Series_WIPO .26 Standards

August 30, 2022

The Big Bang Blog Series – The New WIPO Standard

By:

FDA Guidance Biosimilars Patent Prosecution | Intellectual Property Law Firm | Harness IP

September 20, 2019

FDA Publishes New Guidance Limiting Petitions that Could Delay Biosimilar Applications

By: Leanne M. Rakers, Principal

photo of biosimilar medications

February 7, 2019

Abandoning Infringing Conduct Caused Loss of Standing to Appeal IPR

By: Bryan K. Wheelock, Principal

Harness IP Intellectual Property Lawyers

August 20, 2018

Pfizer’s Biosimilar Antitrust Lawsuit Survives Johnson & Johnson’s Motion to Dismiss

By: Elisabeth A. Koral, Principal

photo of laboratory and scientist creating biosimilar patents

August 9, 2018

FDA Implements Biosimilar Action Plan to Boost Biosimilar Competition

By: Leanne M. Rakers, Principal

image of light bulb to suggest hypothetical biosimilar case study

August 9, 2018

At Risk Launch: A Hypothetical Case Study

By: Douglas A. Robinson, Principal

photo of chess pieces representing biosimilar competitive dynamics

August 8, 2018

Competitor Influence on the Conduct of the Patent Dance and Litigation

By: Elisabeth A. Koral, Principal

photo of biosimilar medications

August 7, 2018

Seeking Biosimilar Market Entry When a Competitor is Pursuing Interchangeability: Factors to Consider

By: Elisabeth A. Koral, Principal

Stay Current on all things IP by subscribing to our blog

Join

  • LinkedIn
  • Facebook
    • Sitemap
    • Privacy Statement
    • Legal Notice

  • © 2025 Harness, Dickey & Pierce, P.L.C. All rights reserved. H D & P